Skip to main content

I saw this on the news last night. It's an antibody with far fewer side effects than many of the other IBD treatments. The drug is still in trials but it seems very promising.

(One thing, I have to check the numbers - it says IBD affects 4 million people worldwide. That seems a little low. Probably more like 40 million)

http://www.ctvnews.ca/health/n...itis-study-1.1420887
Original Post

Replies sorted oldest to newest

Interesting, but unfortunately, the study did not compare it with other treatments, just placebo. Looks like around a 50% response rate, which is OK. What I find amusing is that placebo has a 25% response rate.

There is one member here who has been taking it, Pkitty, who was unable to get into full remission and went to Cleveland Clinic for a j-pouch, only to be diagnosed with Crohn's. So, she's in a holding pattern right now. I guess the Crohn's diagnosis makes sense now, knowing that vedolizumab works better in UC than Crohn's.

It will be interesting to see how this stacks up against the other biologics. I like the fact that it targets the intestine only. Too bad it is by IV infusion only, or it would be perfect!

The (reported) world IBD incidence of 4 million may be about right, since the U.S. incidence is about 1.4 million. Reporting in less developed countries is not very good.

Jan Smiler
Last edited by Jan Dollar
I would like to see the full study. The news report last night said that the drug was tried on individuals who did not respond to other treatments so perhaps that is why there wasn't a direct comparison with other treatments; I guess you could take that as the sample being those with drug resistant UC/Crohns.

But yes, I find it interesting that the placebo also resulted in improvement for a 1/4 of the participants. I wonder what was actually in that placebo.

Wow, the numbers are a lot lower than I thought they would be (even with possible under-reporting from other countries). It just seems that I know so many people who have UC or Crohns. But then again, Canada has one of the highest rates of IBD in the world, so at least here the numbers are proportionately higher.
In the case of IBD, there is also the random incidence of spontaneous remission. This occurs even without placebo. But, yes, with virtually everything, there is a placebo effect, where believing something will work actually affects the outcome (and why they need double blinding, because the scientists can unknowingly affect outcome by their behavior with the people who are getting the actual treatment vs. placebo).

The mind is a powerful thing, and why you need to have a positive attitude going into surgery!

Jan Smiler

Add Reply

Post
Copyright © 2019 The J-Pouch Group. All rights reserved.
×
×
×
×
Link copied to your clipboard.
×